Low-grade glioma: Supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults

Current Neurology and Neuroscience Reports

Volumn 4, Issue 3, 2004, Pages 211-217

  Ashby, Lynn S ^a   Shapiro, William R ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LOMUSTINE;

ANAPLASTIC CARCINOMA; ASTROCYTOMA; BONE MARROW SUPPRESSION; BRAIN TUMOR; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GLIOMA; HUMAN; OLIGODENDROGLIOMA; PRACTICE GUIDELINE; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; ADULT; PATHOLOGY;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; HUMANS; OLIGODENDROGLIOMA; SUPRATENTORIAL NEOPLASMS;

EID: 3042534391     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-004-0041-5     Document Type: Review

References (50)

1. Cairncross JG, Laperriere NJ: Low-grade glioma. To treat or not to treat. Arch Neurol 1989, 46:1238-1239.
2. Rees JH: Low-grade gliomas in adults. Curr Opin Neurol 2002, 15:657-661.
3. Shaw EG: Presendential symposium on low-grade glioma. Neuro-oncol 2003, 5:151-152.
4. Recht LD, Lew R, Smith TW: Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 1992, 31:431-436.
5. Shapiro WR: Low-grade gliomas: when to treat? Ann Neurol 1992, 31:437-438.
6. Perry A: Pathology of low-grade gliomas: an update of emerging concepts. Neuro-oncol 2003, 5:168-178.
7. Reifenberger G, Louis DN: Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropath Exp Neurol 2003, 62:111-126.
8. Engelhard HH, Stelea A, Cochran EJ: Oligodendroglioma: pathology and molecular biology. Surg Neurol 2002, 58:111-117.
9. Kleihues P, Cavenee WK (editors): World Health Organization Classification of Tumours: Pathology and Genetics of Tumors of the Nervous System. Lyon, France: IARC Press; 2000,
10. Kernohan JW, Mabon RG, Svien HL et al.: A simplified classification of the gliomas. Mayo Clin Proc 1949, 24:71-74.
11. Ringertz N: Grading of gliomas. Acta Pathol Microbiol Scand 1950, 27:51-64.
12. Smith MT, Ludwig CL, Godfrey AD, et al.: Grading of oligodendrogliomas. Cancer 1983, 52:2107-2114.
13. Daumas-Duport C, Scheithauer BW, O'Fallon J, et al.: Grading of astrocytomas: a simple and reproducible method. Cancer 1988, 62:2152-2165.
14. Daumas-Duport C, Varlet P, Tucker ML, et al.: Oligodendrogliomas, Part 1: patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neuro-oncol 1997, 34:37-59.
15. Daumas-Duport C, Tucker ML, Kolles H, et al.: Oligodendrogliomas, Part 2: A new grading system based on morphological and imaging criteria. J Neuro-oncol 1997, 35:61-78.
16. Kraus JA, Koopmann J, Kaskel P, et al.: Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995, 54:91-95.
17. Cairncross JG, Ueki K, Zlatescu MC, et al.: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998, 90:1473-1479.
18. Smith JS, Perry A, Borell TJ, et al.: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000, 18:636-645.
19. Hendrikus GJ, Krower MD, Davis RL, et al.: Gemistocytic astrocytomas: a reappraisal. J Neurosurgery 1991, 74:399-406.
20. Watanabe K, Tachibana O, Yonekawa Y, et al.: Role of gemistocytes in astrocytoma progression. Lab Invest 1997, 76:277-284.
21. Ashby LS, Shapiro WR, Spangler WJ, et al.: The presence of gemistocytes predicts for survivorship in oligodendroglial tumors but not in astrocytomas [abstract]. Proc Am Soc Clin Oncol 1999, 18:147a.
22. Coons SW, Pearl DK: Mitosis identification in diffuse gliomas. Cancer 1998, 82:1550-1555.
23. Heegaard S, Sommer HM, Broholm H, et al.: Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer 1995, 76:1809-1813.
24. Coons SW, Johnson PC, Pearl DK: The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery 1997, 41:878-884.
25. Fisher BJ, Naumova E, Leighton CC, et al.: Ki-67: a prognostic factor for low-grade glioma? Int J Radiation Oncology Biol Phys 2002, 52:996-1001.
26. Pietsch T, Wiestler OD: Molecular neuropathology of astrocytic brain tumors. J Neuro-oncol 1997, 35:211-222.
27. Hilton DA, Love S, Barber R, et al.: Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Neurosurgery 1998, 42:724-729.
28. Henderson KH, Shaw EG: Randomized trials of radiation therapy in adult low-grade gliomas. Semin Radiat Oncol 2001, 11:145-151.
29. Keles GE, Lamborn KR, Berger MS: Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001, 95:735-745.
30. Berger MS, Deliganis AV, Dobbins J, et al.: The effect of extent of resection on recurrence in patients with low grade cerebral hemispheric gliomas. Cancer 1994, 74:1784-1791.
31. Schmidt MH, Berger MS, Lamborn KR, et al.: Repeated operations for infiltrative low-grade gliomas without intervening therapy. J Neurosurg 2003, 98:1165-1169.
32. Chamberlain MC, Murovic JA, Levin VA: Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988, 38:1371-1374.
33. Kondziolka D, Lunsford LD, Martinez AJ: Unreliability of contemporary neurodiagnostic imaging in evaluating suspect adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993, 79:533-536.
34. Reiche W, Grunwald I, Hermann K, et al.: Oligodendrogliomas: a comparison of CT and MR imaging features with histological malignancy grading in twenty cases: a pathoradiological study. Acta Radiologica 2002, 43:474-482.
35. Scott JN, Brasher PM, Sevick RJ, et al.: How often are non-enhancing supratentorial gliomas malignant? A population study. Neurology 2002, 59:947-949.
36. Tatter SB: Neurosurgical management of low- and intermediate-grade gliomas. Semin Radiat Oncol 2001, 11:113-123.
37. Whittle IR: Surgery for gliomas. Curr Opin Neurol 2002, 15:663-669.
38. Karim AB, Maat B, Hatlevoll R, et al.: A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844. Int J Radiat Oncol Biol Phys 1996, 36:549-556.
39. Pignatti F, van den Bent M, Curran D, et al.: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002, 20:2076-2084.
40. Shaw E, Arusell R, Scheithauer B, et al.: Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002, 20:2267-2276.
41. Karim AB, Afra D, Cornu P, et al.: Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer 22845 with the Medical Research Council study BR04: An interim analysis. Int J Radiation Oncology Biol Phys 2002, 52:316-324.
42. Jeremic B, Milicic B, Grujicic D, et al.: Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma: a 10-year update of a phase II study. Int J Radiation Oncology Biol Phys 2003, 57:465-471.
43. Hanzely Z, Polgar C, Fodor J, et al.: Role of early radiotherapy in the treatment of supratentorial WHO Grade II astrocytomas: long-term results of 97 patients. J Neuro-oncol 2003, 63:305-312.
44. Mason WP: Chemotherapy for low-grade gliomas. Forum 2000, 10:95-104.
45. Lesser GJ: Chemotherapy of low-grade gliomas. Semin Radiat Oncol 2001, 11:138-144.
46. Cairncross JG, Macdonald D, Ludwin S, et al.: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994, 12:2013-2021.
47. Mason WP: Low-grade oligodendroglioma responds to chemotherapy. Neurology 1996, 46:203-207.
48. Soffietti R, Ruda R, Bradac GB, et al.: PCV chemotherapy for recurrent oligodendrogliomas and oligo- astrocytomas. Neurosurgery 1998, 43:1066-1073.
49. Buckner JC, Gesme D Jr, O'Fallon JR, et al.: Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol 2003, 21:251-255.
50. Eyre HJ, Crowley JJ, Townsend JJ, et al.: A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 1995, 78:909-914.